Medicare Enrolled

Dr. Ryan Houk, M.D.

Cardiovascular Disease · Naples, FL
Practice pattern: Cardiac & Electrophysiology— Practice combining cardiac and electrophysiology services
Low-engagement
730 GOODLETTE RD STE 100, Naples, FL 34102
2396826603
In practice since 2009 (16 years)
NPI: 1053640003 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Houk from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Houk? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Houk

Dr. Ryan Houk is a cardiovascular disease in Naples, FL, with 16 years in practice. Based on federal Medicare data, Dr. Houk performed 10,993 Medicare services across 7,215 unique beneficiaries.

Between the years covered by Open Payments, Dr. Houk received a total of $4,232 from 20 pharmaceutical and/or device companies across 243 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Houk is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice▲ Top 6% volume in FL$ $4,232 industry payments

Medicare Practice Summary

Medicare Utilization ↗
10,993
Medicare services
Top 6% in FL for cardiovascular disease
7,215
Unique beneficiaries
$210
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~687 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Regadenoson injection (Lexiscan) for heart stress test2,333$43$123
Electrocardiogram (EKG), 12-lead1,890$11$34
Office visit, established patient (30-39 min)1,831$93$267
Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries1,157$311$798
Echocardiogram, transthoracic945$148$402
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician664$54$150
Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan579$2,165$5,517
Nuclear medicine study of heart muscle blood flow by pet572$147$376
New patient office visit (45-59 min)252$114$354
Office visit, established patient (20-29 min)158$63$190
Hospital follow-up visit, high complexity108$97$213
Technetium tc-99m tetrofosmin, diagnostic, per study dose80$351$896
Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional47$21$53
Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional47$659$1,832
Electrocardiogram (ecg) 2-day continuous with review and report by health care professional46$50$156
Nuclear medicine studies of heart muscle at rest and with stress and spect39$337$903
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician36$11$29
Heart muscle strain imaging25$30$79
Initial hospital admission, high complexity21$138$414
New patient office visit (30-44 min)20$83$238
External shock to heart to regulate heart beat19$88$327
Nuclear medicine study, spect imaging, 1 area or single acquisition, single day imaging18$284$726
Ultrasound of heart with probe in esophagus, with report17$82$223
Ultrasound of heart blood flow, valves and chambers17$14$37
Ultrasound of heart with color-depicted blood flow, rate and valve function17$2$6
Ultrasound of heart, follow-up15$74$200
Ultrasound of heart blood flow, valves and chambers, follow-up15$19$61
Technetium tc-99m pyrophosphate, diagnostic, per study dose, up to 25 millicuries14$89$114
Nuclear medicine study of heart pumping function by labeling red blood cells with measurement of internal blood volume ejected with every beat over multiple cycles11$171$435
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
9.0% high complexity
39.2% medium
51.8% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$4,232
Total received (2018-2024)
Avg $605/year across 7 years
Top 43% in FL for cardiovascular disease
20
Companies
243
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,157 (98.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$75 (1.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$791
2023
$748
2022
$112
2021
$435
2020
$256
2019
$639
2018
$1,252

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Pharmaceuticals, Inc
$1,065
Abbott Laboratories
$794
Novartis Pharmaceuticals Corporation
$465
GE HEALTHCARE
$246
PFIZER INC.
$232
Amgen Inc.
$229
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$224
Kestra Medical Technology Services, Inc.
$191
Edwards Lifesciences Corporation
$137
Alnylam Pharmaceuticals Inc.
$132
AstraZeneca Pharmaceuticals LP
$91
Boston Scientific Corporation
$91
Astellas Pharma US Inc
$75
CVRx, Inc.
$69
Boehringer Ingelheim Pharmaceuticals, Inc.
$54
Esperion Therapeutics, Inc.
$42
Philips North America LLC
$35
Medtronic, Inc.
$24
Medtronic Vascular, Inc.
$23
BRACCO DIAGNOSTICS INC.
$13
Top 3 companies account for 54.9% of total payments
Associated products mentioned in payments ›
(CM9) Amb Mon & Diag Und · 3F · Assure WCD · Assurity Pacemaker · Barostim Neo System · Cardiogen-82 · Confirm Rx · Corlanor · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · ENTRESTO · Ensite Cardiac Mapping System · FARXIGA · FlexAbility Ablation Catheter · HeartMate · JARDIANCE · LEQVIO · LifeVest · MERLIN@HOME · MICRA · Merlin Connectivity and Remote · NEXLETOL · ONPATTRO · PRADAXA · Quadra Allure MP RF CRT Pacemkr · Quadra Assura CRT Defibrillator · Repatha · Therapy Ablation Catheter · VYNDAMAX · VYNDAQEL · WATCHMAN FLX · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $38 per 100 Medicare services performed
Looking for a cardiovascular disease in Naples?
Compare cardiovascular diseases in the Naples area by procedure volume, costs, and industry payment transparency.
Browse cardiovascular diseases nearby

Geographic Context

Cardiovascular Diseases within 10 mi
46
Per 100K population
11.9
County median income
$86,173
Nearest hospital
NAPLES COMMUNITY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Houk is a cardiac & electrophysiology specialist, with above-average Medicare volume (top 6% in FL), and low-engagement industry engagement, with 16 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Houk experienced with regadenoson injection (lexiscan) for heart stress test?
Based on Medicare claims data, Dr. Houk performed 2,333 regadenoson injection (lexiscan) for heart stress test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Houk receive payments from pharmaceutical companies?
Yes. Dr. Houk received a total of $4,232 from 20 companies across 243 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Houk's costs compare to other cardiovascular diseases in Naples?
Dr. Houk's average Medicare payment per service is $210. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Houk) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →